NASDAQ:CTXR   Citius Pharmaceuticals, Inc.
Big resistance at 2.53 for CTXR. Hopefully phase 3 talk soon will be the catalyst to cross that.

Could be a nice swing. Target 3$ a share.

This is not financial advice. Do your own DD. Your capital is at risk.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。